Total Payments
$3,138
2024 Payments
$826.84
Companies
26
Transactions
162
Medicare Patients
2,851
Medicare Billing
$104,850
Payment Breakdown by Category
Food & Beverage$3,138 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,138 | 162 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $659.55 | 14 | $0 (2024) |
| ABBVIE INC. | $592.79 | 53 | $0 (2024) |
| Novo Nordisk Inc | $368.20 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $349.24 | 10 | $0 (2023) |
| GlaxoSmithKline, LLC. | $255.77 | 11 | $0 (2024) |
| Lilly USA, LLC | $177.71 | 8 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $120.99 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94.77 | 7 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $67.10 | 5 | $0 (2024) |
| Amgen Inc. | $60.27 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $826.84 | 55 | ABBVIE INC. ($259.11) |
| 2023 | $1,396 | 71 | AstraZeneca Pharmaceuticals LP ($337.54) |
| 2022 | $914.84 | 36 | Bayer HealthCare Pharmaceuticals Inc. ($188.08) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: Obesity | ||||||
| 10/26/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: ANTIBIOTIC | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Obesity | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $0.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,947 | 2,944 | $246,076 | $69,106 |
| 2022 | 15 | 904 | 1,190 | $126,208 | $35,744 |
Total Patients
2,851
Total Services
4,134
Medicare Billing
$104,850
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 355 | 749 | $165,529 | $42,066 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $20,040 | $5,048 | 25.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 301 | 527 | $4,216 | $4,117 | 97.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 206 | 254 | $7,620 | $2,610 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 49 | $7,399 | $2,343 | 31.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 163 | 176 | $10,736 | $2,261 | 21.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 226 | 280 | $6,160 | $2,117 | 34.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 111 | 189 | $5,103 | $1,783 | 34.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $4,690 | $1,391 | 29.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $1,360 | $1,113 | 81.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 41 | 41 | $1,845 | $896.28 | 48.6% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 13 | 13 | $1,105 | $590.46 | 53.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 26 | 28 | $1,316 | $460.88 | 35.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 16 | $1,024 | $329.84 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 33 | $1,122 | $302.40 | 27.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 26 | 35 | $840.00 | $290.15 | 34.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 45 | 47 | $752.00 | $281.87 | 37.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 26 | $910.00 | $243.99 | 26.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 46 | 48 | $672.00 | $239.52 | 35.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 64 | 74 | $444.00 | $162.80 | 36.7% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 20 | 22 | $308.00 | $107.50 | 34.9% |
| 83550 | Iron binding capacity | Office | 2023 | 11 | 12 | $288.00 | $102.84 | 35.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 11 | 12 | $360.00 | $89.84 | 25.0% |
| 83540 | Iron level | Office | 2023 | 13 | 14 | $252.00 | $88.76 | 35.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 80 | $800.00 | $53.86 | 6.7% |
About Dr. Sean Koch, MD
Dr. Sean Koch, MD is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1184112112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Koch, MD has received a total of $3,138 in payments from pharmaceutical and medical device companies, with $826.84 received in 2024. These payments were reported across 162 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,138).
As a Medicare-enrolled provider, Koch has provided services to 2,851 Medicare beneficiaries, totaling 4,134 services with total Medicare billing of $104,850. Data is available for 2 years (2022–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wynne, AR
- Active Since 04/25/2018
- Last Updated 08/08/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184112112
Products in Payments
- FARXIGA (Drug) $412.67
- Kerendia (Drug) $349.24
- VRAYLAR (Drug) $213.31
- UBRELVY (Drug) $176.71
- Rybelsus (Drug) $151.24
- TRELEGY ELLIPTA (Drug) $148.96
- AIRSUPRA (Drug) $137.63
- QULIPTA (Drug) $135.52
- MOUNJARO (Drug) $121.09
- QUVIVIQ (Drug) $120.99
- Ozempic (Drug) $120.29
- BREZTRI (Drug) $109.25
- Wegovy (Drug) $96.67
- JARDIANCE (Drug) $94.77
- GEMTESA (Drug) $83.45
- LINZESS (Drug) $54.22
- Otezla (Drug) $46.78
- Cologuard Collection Kit (Device) $45.42
- VAXELIS (Biological) $43.81
- QELBREE (Drug) $38.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wynne
Dr. Mark Bradshaw, M.d, M.D
Family Medicine — Payments: $5,627
Family Medicine $5,627
Dr. Willard Burks, M.d, M.D
Family Medicine — Payments: $5,354
Family Medicine $5,354
Dr. James Cathey, M.d, M.D
Family Medicine — Payments: $4,594
Family Medicine $4,594
Dr. James Beaton, M.d, M.D
Family Medicine — Payments: $3,374
Family Medicine $3,374
Jeremiah Nugent, M.d, M.D
Family Medicine — Payments: $2,336
Family Medicine $2,336
Mrs. Lesli Anderson, Aprn, APRN
Family Medicine — Payments: $390.90
Family Medicine $390.90